| Product NDC: | 52584-165 |
| Proprietary Name: | Dexamethasone Sodium Phosphate |
| Non Proprietary Name: | Dexamethasone Sodium Phosphate |
| Active Ingredient(s): | 4 mg/5mL & nbsp; Dexamethasone Sodium Phosphate |
| Administration Route(s): | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52584-165 |
| Labeler Name: | General Injectables & Vaccines, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA084916 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110718 |
| Package NDC: | 52584-165-05 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BAG (52584-165-05) > 5 mL in 1 VIAL, MULTI-DOSE |
| NDC Code | 52584-165-05 |
| Proprietary Name | Dexamethasone Sodium Phosphate |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BAG (52584-165-05) > 5 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 52584-165 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dexamethasone Sodium Phosphate |
| Dosage Form Name | INJECTION |
| Route Name | INTRA-ARTICULAR; INTRALESIONAL; INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20110718 |
| Marketing Category Name | ANDA |
| Labeler Name | General Injectables & Vaccines, Inc. |
| Substance Name | DEXAMETHASONE SODIUM PHOSPHATE |
| Strength Number | 4 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |